TELA Bio, Inc. (TELA)
$1.10+2.80%Close
SELLCRISIS · day 9
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $49M
- Beta
- 1.36
- P/E (TTM)
- -1.42
- Short % float
- 1.43%
- Days to cover
- 1.8
- SI change
- -14.8%
- 1W
- +2.80%
- 1M
- +0.92%
- vs SPY 1W
- +2.94%
- vs SPY 1M
- -1.59%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 2
- VALUE
- 12
- GROWTH
- 36
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-
REV YoY-
ROE-
EPS YoY-
ROA-68.9%
GROSS68
OP-43
NET-52
[VALUATION]
P/E TTM-1.42
P/E FWD-
SECTOR PE20.48
INDUSTRY PE22.31
P/B-3.96
P/FCF-
EV/EBITDA-2.28
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO2.99
ND/EBITDA-
BETA1.36
Company news
FAQ
- What is LOPJLB’s current signal on TELA?
- LOPJLB’s latest quantitative signal on TELA Bio, Inc. (TELA) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is TELA in?
- TELA Bio, Inc. (TELA) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does TELA Bio, Inc. (TELA) do?
- TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patientâs anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Ti…